Yersinia outer-membrane protein B (YopB): a tool for identification of Yersinia pestis isolates Yersiniae that are pathogenic to humans include Yersinia pestis, Yersinia pseudotuberculosis and Yersinia enterocolitica. Y. pestis is the cause of bubonic plague, which is transmitted by fleas. Common to all of these species is the presence of a 70 kb virulence plasmid that harbours a type III secretion system, and several secreted and translocated proteins called Yersinia outer proteins or Yops (Cornelis, 2002) . The plasmid-encoded type III secretion system enables yersiniae to survive and proliferate extracellularly in host lymphatic tissues (Trülzsch et al., 2004) . Three of the Yops -YopB, YopD and LcrV -are required for translocation of the others across the target-cell membrane (Viboud et al., 2003) . The hydrophobic YopB and YopD thus seem to be central for translocation of the effectors and for the formation of a channel in lipid membranes. Presumably they play different roles in pore formation (Cornelis, 2000) . Indeed, YopB alone can disturb artificial membranes, whereas YopD cannot (Francis & Wolf-Watz, 1998) . Accurate laboratory identification guarantees the safe control and handling of specimens and is essential for surveillance of the spread of Y. pestis in natural plague foci (Anisimov et al., 2004) . The present study was aimed at developing a Y. pestis-specific PCR for the yopB gene and a specific immunoassay for detection or typing of Y. pestis strains. The isolates used to characterize these assays were from human patients and rodent samples from 1994 outbreak regions (Batra et al., 1996) , and from surveillance studies of the Deccan plateau region (U. Tuteja, J. Shukla & H. V. Batra, unpublished data) ( Table 1 ). Plasmid DNA was extracted from cultures by alkaline lysis (Maniatis et al., 1982) . The entire 70 kb/low-calcium response locus plasmid sequence (GenBank accession no. AF074612) was used to design Y. pestis-specific primers for the yopB gene using DNASIS software. The primer sequences were 59-AAAAATGGCGGGGTGAGTT-39 (forward) and 59-AAAACTCGGCTCCTT-TAGC-39 (reverse). PCR amplification was carried out in a 50 ml reaction mixture containing the extracted bacterial plasmid (50 ng) isolated from the Y. pestis isolates and standard strains, 200 mM each dNTP, 1 mM each primer, 1 U Taq polymerase and 106 buffer (Qiagen) using a Perkin Elmer model 480 thermal cycler. Amplification consisted of 30 cycles of 94˚C for 1 min, 48˚C for 1 min and 72˚C for 2 min. PCR products were analysed on a 1?5 % agarose gel (Fig. 1) . The yopB gene 700 bp amplicon was detected from standard Y. pestis A1122, but other Yersinia ( Fig. 1 ) and non-Yersinia (not shown) species were negative. All 18 isolates from human and rodent samples from outbreak regions were able to produce the 700 bp amplification product, while two of the isolates from rodents from the surveillance region were negative for the yopB gene (Table 1 ). The 700 bp PCR product was cloned into the pQE-32 expression vector by ligation using SmaI and Klenow fragment blunt-ended DNA, and transformed into Escherichia coli SG13009 cells (Sambrook et al., 1989) . Recombinant clones were confirmed by restriction analysis and PCR (using SmaI and the same primers as above) (not shown). Expression of recombinant YopB protein was obtained by inoculating cultures, growing them overnight in LB broth and then inducing expression with 1 mM IPTG. Whole-cell lysates of the bacteria were prepared and expression of the recombinant protein was examined by 10 % SDS-PAGE (Laemmli, 1970 immunoglobulin serum antibody titres were determined 7 days after the last booster by dot-ELISA (Khushiramani et al., 2004) . After the fourth dose, rabbit and mice antibody titres were determined as 1 : 64 000 by dot-ELISA. The hyperimmune sera were used in Western blotting (Towbin et al., 1979) to check their reactivity against the native Y. pestis Yop proteins and the recombinant protein. Rabbit polyclonal antibodies raised against rYop detected bands of 28 kDa in cell lysates from IPTG-induced recombinant E. coli SG13009 and 41 kDa for native antigens of Y. pestis (Fig. 2) . This finding suggested that the antigenicity of the recombinant protein was maintained. In another study, the same recombinant protein was also found to be biologically active. Both the truncated rYopB and rLcrV in the in vitro studies inhibited LPS-induced tumour necrosis factor-a, gamma interferon, keratinocyte-derived chemokine, IP-10, interleukin 12 and NO production in murine peritoneal macrophages Sodhi et al., 2004) .
To check variation at the epitope level, mAbs were prepared following a standard PEG fusion protocol (Köhler & Milstein, 1975) . mAbs produced by the hybridoma were screened by dot-ELISA. A total of ten stable mAbs was obtained against truncated rYopB protein. (Table 1) . mAbs generated in the present study could be utilized to study the exact mechanism of action of YopB proteins and their receptors. As these mAbs are specific to Y. pestis and as variation in the yopB gene of isolates was also observed, this PCR and immunoassay could be used as simple, rapid and cost-effective methods for the typing of Y. pestis strains.
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